2. Pagerina PKS sergan\u010di\u0173 moter\u0173 kiau\u0161in\u0117li\u0173 kokyb\u0119<\/strong><\/h4>\n\n\n\nMoter\u0173 kiau\u0161in\u0117li\u0173 kokyb\u0117 yra itin svarbi sveika, n\u0117\u0161tumui, bet j\u0105 gali sugadinti daugyb\u0117 faktori\u0173, tarp j\u0173 – moters am\u017eius, gyvenimo b\u016bdas, streso lygiai, mityba ir, \u017einoma, PKS.<\/p>\n\n\n\n
Pasak studijos, publikuotos \u017eurnale \u201eFertility and Sterility\u201c, moter\u0173, du kartus per dien\u0105 vartojusi\u0173 4 g inozitolio bei 400 \u00b5g folio r\u016bg\u0161ties, kiau\u0161in\u0117li\u0173 kokyb\u0117 buvo geresn\u0117 <\/strong>nei moter\u0173, vartojusi\u0173 tik folio r\u016bg\u0161t\u012f (8).<\/p>\n\n\n\nTaigi, jei greitu metu ketinate pastoti, rekomenduojame kuo anks\u010diau prad\u0117ti vartoti Chromositol-F ir u\u017etikrinti ger\u0105 kiau\u0161in\u0117lio sveikat\u0105.<\/strong><\/p>\n\n\n\n
3. Atstato normal\u0173 menstruacij\u0173 cikl\u0105<\/strong><\/h4>\n\n\n\n2010 m. atlikto tyrimo metu nustatyta, kad inozitolio ir folio r\u016bg\u0161ties derinys ne tik atstat\u0117 menstruacij\u0173 cikl\u0105, bet ir pagerino n\u0117\u0161tumo da\u017enum\u0105<\/strong> (9)!<\/p>\n\n\n\n4. Pagerina vaisingum\u0105<\/strong><\/h4>\n\n\n\nTaigi, kiau\u0161in\u0117lio kokyb\u0117 veikia ir moters vaisingum\u0105. Kaip jau \u017einote, inozitolis gali pagerinti moters kiau\u0161in\u0117lio kokyb\u0119 ir atkurti menstruacij\u0173 cikl\u0105.<\/p>\n\n\n\n
Prid\u0117jus ir kit\u0105 inozitolio milteli\u0173 naud\u0105, nenuostabu, kad jis taip pat teigiamai veikia moter\u0173 vaisingum\u0105<\/strong> (8, 9).<\/p>\n\n\n\n5. \u017demesnis PKS sergan\u010di\u0173 moter\u0173 testosterono lygis<\/strong><\/h4>\n\n\n\nNors testosteronas yra vyri\u0161kas hormonas, jis nat\u016braliai egzistuoja tiek vyr\u0173, tiek moter\u0173 organizmuose. Visgi, moter\u0173, sergan\u010di\u0173 PKS, testosterono lygis yra auk\u0161tesnis nei \u012fprasta.<\/strong> \u0160tai tod\u0117l dauguma PKS sergan\u010di\u0173 moter\u0173 jau\u010dia \u201evyri\u0161kus\u201c simptomus. Hirsutizmas, arba padid\u0117j\u0119s plauk\u0173 augimas vyrams b\u016bdingose vietose, moteri\u0161kas plauk\u0173 slinkimas, sunki akn\u0117 ir nereguliarios menstruacijos.<\/p>\n\n\n\nVartodajant inozitol\u012f ir folio r\u016bg\u0161t\u012f<\/strong> (pagrindinius Chromositol-F ingredientus), testosterono lygis gr\u012f\u017eta \u012f norm\u0105. Tai padeda PKS sergan\u010dioms moterims suvaldyti akn\u0119 ir hirsutizm\u0105 bei pagerinti ovuliacij\u0105 ir vaisingum\u0105 (2).<\/p>\n\n\n\n6. Sustabdo hirsutizm\u0105<\/strong><\/h4>\n\n\n\nKai kurios moterys pozityviai priima hirsutizm\u0105 (ar bent bando su juo susigyventi), bet kitoms tai sunkiau. Jei priklausote pastarajai grupei, pabandykite inozitol\u012f! 2008 m. atliktas tyrimas pademonstravo, kaip puikiai inozitolis subalansuoja lytinius hormonus. Po 6 m\u0117nesi\u0173 vartojimo, 46 nuo hirsutizmo kent\u0117jusios moterys sustabd\u0117 nepageidaujam\u0173 plauk\u0173 augim\u0105<\/strong>! Inozitolis pad\u0117jo suma\u017einti androgen\u0173 ir padidinti estrogen\u0173 lygius (10).<\/p>\n\n\n\n
7. Apsaugo nuo gestacinio diabeto<\/strong><\/h4>\n\n\n\nDaugyb\u0117 moter\u0173 n\u0117\u0161tum\u0105 laiko gyvenimo dovana. Bet pastojimas yra tik pirmas jo \u017eingsnis. Kita u\u017eduotis \u0161iame darb\u0173 s\u0105ra\u0161e – apsisaugojimas nuo gestacinio diabeto<\/strong>. Kod\u0117l? Nes jis gali sukelti daug problem\u0173. Jis gali sukelti preeklampsij\u0105 (auk\u0161t\u0105 kraujosp\u016bd\u012f), hipoglikemij\u0105 (\u017eem\u0105 cukraus lyg\u012f kraujyje) ir itin didel\u012f k\u016bdikio augim\u0105 (d\u0117l ko jo pagimdyti tiesiog ne\u012fmanoma).<\/p>\n\n\n\nDeja, gestacinis diabetas da\u017enai paplit\u0119s tarp nutukusi\u0173 ir vir\u0161svorio turin\u010di\u0173 n\u0117\u0161\u010di\u0173j\u0173. Laimei, inozitolis gali pad\u0117ti suma\u017einti \u0161i\u0173 moter\u0173 gestacinio diabeto rizik\u0105<\/strong> (11).<\/p>\n\n\n\nSiekdamos jo i\u0161vengti, moterys, sergan\u010dios PKS ir\/ar \u0161eimos istorijoje turin\u010dios antrojo diabeto, tur\u0117t\u0173 pagalvoti apie inozitolio papild\u0173 vartojim\u0105 gestacinio diabeto prevencijai.<\/p>\n\n\n\n
8. Pagalba moterims po menopauz\u0117s<\/strong><\/h4>\n\n\n\nMenstruacijos yra vienas nepatogiausi\u0173 dalyk\u0173, vykstan\u010di\u0173 moter\u0173 gyvenimuose. Keturiasde\u0161imt met\u0173, kiekvien\u0105 m\u0117nes\u012f, tiksliai kaip laikrodis kraujuojame net kelias dienas! Taigi, nesunku pagalvoti, kad pasiekus menopauz\u0119 pagaliau gal\u0117sime pails\u0117ti.<\/p>\n\n\n\n
Bet su menopauze susij\u0119s estrogeno ir progesterono lygi\u0173 suma\u017e\u0117jimas irgi gali pabloginti sveikatos b\u016bkl\u0119, <\/strong>padidindamas metabolinio sindromo ir \u0161irdies ir kraujagysli\u0173 lig\u0173 i\u0161sivystymo rizik\u0105.<\/p>\n\n\n\nSiekiant suvaldyti \u0161iuos sveikatos sutrikimus, rekomenduojamas sveikas gyvenimo b\u016bdas ir subalansuota mityba, bet inozitolio vartojimas irgi padeda. Pasak neseno tyrimo, kasdien\u0117s 2 g inozitolio doz\u0117s puikiai pakanka cholesterolio ir triglicerid\u0173 lygio, kraujosp\u016bd\u017eio ir HOMA indekso pagerinimui <\/strong>(12).<\/p>\n\n\n\n
9. Padeda atsikratyti hormonin\u0117s akn\u0117s <\/strong><\/h4>\n\n\n\nObuoli\u0173 actas, medus, hamamelis, \u017ealioji arbata, alavijas, arbatmed\u017eio aliejus – akn\u0117s gydymo b\u016bd\u0173 tikrai netr\u016bksta. Kai kurie \u0161i\u0173 variant\u0173 galb\u016bt ir veikia, bet jei j\u016bs\u0173 akn\u0117 yra hormonin\u0117 (kaip b\u016bna PKS atveju), n\u0117 vienas j\u0173 gali nepad\u0117ti<\/strong>. Tokiu atveju jums pad\u0117s inozitolis.<\/p>\n\n\n\nItal\u0173 tyr\u0117jai penkiasde\u0161im\u010diai PKS pacien\u010di\u0173 su vidutinio sunkumo akne 6 m\u0117nesius du kartus per dien\u0105 dav\u0117 2 g inozitolio. Tyrimo pabaigoje inozitol\u012f vartojusi\u0173 pacien\u010di\u0173 kraujyje nustatytas ma\u017eesnis DHEA-S (dehidroepiandrosterono sulfato) lygis ir fiksuota pager\u0117jusi odos b\u016bkl\u0117<\/strong>! Tai leido tyr\u0117jams teigti, kad inozitolis gali b\u016bti vartojamas hormonin\u0117s akn\u0117s gydymui (4).<\/p>\n\n\n\n10. Padeda kr\u016btimi maitinan\u010dioms mamoms<\/strong><\/h4>\n\n\n\nPrie\u0161 vartojant daugum\u0105 maisto papild\u0173 ir vaist\u0173, svarbu pasitarti su savo gydytoju, o ypa\u010d jei maitinate kr\u016btimi. I\u0161ties, motinos piene yra nat\u016braliai daug inozitolio – tai tre\u010dias did\u017eiausios koncentracijos elementas motinos piene, po laktoz\u0117s ir gliukoz\u0117s (16).<\/p>\n\n\n\n
Inozitolis vyrams – padeda pagerinti spermos kokyb\u0119 ir vaisingum\u0105<\/strong><\/h3>\n\n\n\nPasak tyrimo, publikuoto \u201eInternational Journal of Endocrinology\u201c \u017eurnale, 45 vyrai, kent\u0119 nuo metabolinio sindromo ir astenospermijos, 3 m\u0117nesius du kartus per dien\u0105 vartojo 1 g inozitolio (ir antioksidant\u0173). Tyrimo pabaigoje savanoriai pademonstravo \u017eenkliai didesn\u012f jautrum\u0105 insulinui, auk\u0161tesn\u012f testosterono lyg\u012f bei pager\u0117jusi\u0105 spermos kokyb\u0119<\/strong> (judrumas, koncentracija ir morfologija) (13). <\/p>\n\n\n\n
Inozitolio doz\u0117<\/strong><\/h2>\n\n\n\nPrie\u0161ingai nei dauguma kit\u0173 maistini\u0173 med\u017eiag\u0173, inozitolis neturi rekomenduojamos paros normos (RPN). Taip yra tod\u0117l, kad jis n\u0117ra laikomas b\u016btin\u0105ja maistine med\u017eiaga, nes k\u016bnas gali pats jo pagaminti. Bet \u0161tai kelios si\u016blomos inozitolio doz\u0117s, pad\u0117sian\u010dios suvaldyti \u012fvairius sveikatos sutrikimus:<\/p>\n\n\n\n
\nJautrumas insulinui – 2 g du kartus per dien\u0105 (2 Chromositol-F doz\u0117s)<\/li>\n\n\n\n Antrojo tipo diabetas – 2 g du kartus per dien\u0105 (2 Chromositol-F doz\u0117s)<\/li>\n\n\n\n PKS – 2 g du kartus per dien\u0105 + 400 \u00b5g folio r\u016bg\u0161ties (2 Chromositol-F doz\u0117s)\n\nGeresnei kiau\u0161in\u0117li\u0173 kokybei<\/li>\n\n\n\n Menstruacij\u0173 atk\u016brimui<\/li>\n\n\n\n Geresniam vaisingumui<\/li>\n\n\n\n Ma\u017eesniam testosterono lygiui<\/li>\n\n\n\n Hirsutizmo atsikratymui<\/li>\n\n\n\n Liekn\u0117jimui<\/li>\n\n\n\n Hormoninei aknei<\/li>\n<\/ul>\n<\/li>\n\n\n\n Metabolinis sindromas \u2013 2 g du kartus per dien\u0105 (2 Chromositol-F doz\u0117s)\n\nMa\u017eesniam triglicerid\u0173 lygiui kraujyje\u00a0<\/li>\n\n\n\n \u017demesniam MTL ir bendram cholesteroliui\u00a0<\/li>\n\n\n\n Kraujosp\u016bd\u017eio ma\u017einimui<\/li>\n\n\n\n \u017demesniam cukraus lygio kraujyje<\/li>\n<\/ul>\n<\/li>\n\n\n\n Depresija \u2013 12 g 4 savaites (6 Chromositol-F doz\u0117s)<\/li>\n\n\n\n Panikos sutrikimas \u2013 12 g 4 savaites (6 Chromositol-F doz\u0117s)<\/li>\n\n\n\n Obsesinis-kompulsinis sutrikimas \u2013 18 g 6 savaites (9 Chromositol-F doz\u0117s)<\/li>\n\n\n\n Bipolinis sutrikimas \u2013 2 g inozitolio (1 Chromositol-F doz\u0117) + 3 g omega-3<\/li>\n\n\n\n Li\u010dio sukelta psoriaz\u0117 \u2013 3 g kasdien (1,5 Chromositol-F doz\u0117s)<\/li>\n\n\n\n Gestacinis diabetas \u2013 2 g du kartus per dien\u0105 + 400 \u00b5g folio r\u016bg\u0161ties (2 Chromositol-F doz\u0117s)<\/li>\n\n\n\n Moterims po menopauz\u0117s \u2013 2 g du kartus per dien\u0105 (2 Chromositol-F doz\u0117s)<\/li>\n\n\n\n Maitinan\u010dioms motinoms \u2013 2-4 g per dien\u0105 (1-2 Chromositol-F doz\u0117s)<\/li>\n<\/ul>\n\n\n\nGalimas inozitolio \u0161alutinis poveikis<\/strong><\/h2>\n\n\n\nKaip galb\u016bt jau supratote, analizuodami auk\u0161\u010diau pateikt\u0105 lentel\u0119, daugumai sveikatos sutrikim\u0173 gydyti reikia kasdien\u0117s 4 g inozitolio milteli\u0173 doz\u0117s arba 2 Chromositol-F dozi\u0173. Visgi, net ir vartojant dideles jo dozes, siekian\u010dias 18 g, inozitolis vistiek yra laikomas pakankamai saugiu preparatu, o jo \u0161alutinis poveikis i\u0161lieka palyginti \u017eemas<\/strong>. Galimas \u0161alutinis poveikis – pykinimas, galvos skausmas, galvos svaigimas, nuovargis, duj\u0173 kaupimasis ir skrand\u017eio skausmas (15).<\/p>\n\n\n\nKai kurie \u017emon\u0117s nepageidaujam\u0105 \u0161alutin\u012f poveik\u012f gali jausti pirmosiomis vartojimo dienomis. Norint pripratinti k\u016bn\u0105 prie \u0161io papildo, rekomenduojame i\u0161 prad\u017ei\u0173 vartoti ma\u017eesn\u0119 doz\u0119 (2 g). Po keli\u0173 dien\u0173 galite kasdien\u0119 doz\u0119 padidinti iki 4 g.<\/p>\n\n\n
\n
Da\u017eniausiai u\u017eduodami klausimai apie mio-inozitol\u012f<\/strong><\/h2>\n\n\n\nAr galiu inozitolio gauti su maistu?<\/strong><\/p>\n\n\n\nTaip, inozitolio gausu daugyb\u0117je maisto produkt\u0173. \u0160tai keli i\u0161 j\u0173:<\/p>\n\n\n\n
\nDar\u017eov\u0117s – \u017ealios lapin\u0117s dar\u017eov\u0117s, paprikos, \u0161paragai, bulv\u0117s<\/li>\n\n\n\n Pupel\u0117s<\/li>\n\n\n\n Vaisiai – \u0161vie\u017ei citrusiniai vaisiai, tokie kaip apelsinai, kriau\u0161\u0117s, persikai, melionai, bananai<\/li>\n\n\n\n Pilni gr\u016bdai – rudieji ry\u017eiai, kvie\u010di\u0173 s\u0117lenos, kukur\u016bzai<\/li>\n\n\n\n Rie\u0161utai ir s\u0117klos<\/li>\n\n\n\n M\u0117sa ir kiau\u0161iniai<\/li>\n<\/ul>\n\n\n\nKas nutiks jei vir\u0161ysiu rekomenduojam\u0105 doz\u0119?<\/strong><\/p>\n\n\n\nInozitolio milteliai yra pakankamai saugus maisto papildas. Tyrimuose, kuriuose dalyvav\u0119 savanoriai kasdien vartojo 12-18 g inozitolio, buvo u\u017efiksuotas tik \u0161velnus \u0161alutinis poveikis, toks kaip duj\u0173 kaupimasis, pykinimas, nuovargis ir skrand\u017eio skausmai.<\/p>\n\n\n\n
Ar galiu inozitol\u012f vartoti kaip saldikl\u012f?<\/strong><\/p>\n\n\n\nInozitolis yra apie 50 % saldesnis nei \u012fprastas cukrus. J\u012f galite naudoti kavai ar arbatai pasaldinti.<\/p>\n\n\n\n
Ar inozitolio milteliai tinka ketogeninei dietai?<\/strong><\/p>\n\n\n\nTie, kurie laikosi ketogenin\u0117s dietos, turb\u016bt netur\u0117t\u0173 vartoti inozitolio, nes tai gryni angliavandeniai: 1 g inozitolio yra 1 g angliavandeni\u0173. Jei norite likti ketoz\u0117je, rekomenduojama suvartoti ma\u017eiau nei 20 g angliavandeni\u0173 per dien\u0105. Bet 20 g limitas n\u0117ra galutinis. Kai kurie \u017emon\u0117s gali vartoti iki 30, 40 ar net 50 gram\u0173 gryn\u0173j\u0173 angliavandeni\u0173 per dien\u0105 ir i\u0161likti ketoz\u0117je!<\/p>\n\n\n\n
Dauguma inozitolio papild\u0173 rekomenduoja vartoti 2-4 g inozitolio per dien\u0105. Jums teliko nuspr\u0119sti, ar inozitolio nauda sveikatai verta angliavandeni\u0173.<\/p>\n\n\n\n
I\u0161vados<\/strong><\/h2>\n\n\n\nInozitolio milteli\u0173 vartojimas suteikia didel\u0119 naud\u0105. Tai saugus maisto papildas, kurio \u012fprast\u0105 doz\u0119 galite vir\u0161yti net 4 kartus (nuo 4 g iki 18 g per dien\u0105). Net ir vartojant dideles jo dozes, \u0161alutinis poveikis i\u0161lieka nedidelis.<\/p>\n\n\n\n
Jei dar nevartojate inozitolio milteli\u0173, ar susim\u0105stysite apie \u0161i\u0105 galimyb\u0119 perskait\u0119 apie vis\u0105 jo naud\u0105? Pasisakykite komentaruose \u017eemiau!<\/p>\n\n\n\n
\n\n
\n\n
\u201c\u0160altiniai\u201d<\/summary>\n\n(1) Bevilacqua, Arturo, and Mariano Bizzarri. \u201cInositols in Insulin Signaling and Glucose Metabolism.\u201d International journal of endocrinology vol. 2018 1968450. 25 Nov. 2018, doi:10.1155\/2018\/1968450 (2) Costantino, D et al. \u201cMetabolic and hormonal effects of myo-inositol in women with polycystic ovary syndrome: a double-blind trial.\u201d European review for medical and pharmacological sciences vol. 13,2 (2009): 105-10. (3) Tabrizi, Reza et al. \u201cThe effects of inositol supplementation on lipid profiles among patients with metabolic diseases: a systematic review and meta-analysis of randomized controlled trials.\u201d Lipids in health and disease vol. 17,1 123. 24 May. 2018, doi:10.1186\/s12944-018-0779-4 (4) Pezza, Michele, and Valentina Carlomagno. \u201cInositol in Women Suffering from Acne and PCOS: a Randomized Study.\u201d Global Dermatology, vol. 4, no. 1, 2017, doi:10.15761\/god.1000203. (5) Levine, J. \u201cControlled trials of inositol in psychiatry.\u201d European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology vol. 7,2 (1997): 147-55. doi:10.1016\/s0924-977x(97)00409-4 (6) Wozniak, Janet et al. \u201cA randomized clinical trial of high eicosapentaenoic acid omega-3 fatty acids and inositol as monotherapy and in combination in the treatment of pediatric bipolar spectrum disorders: a pilot study.\u201d The Journal of clinical psychiatry vol. 76,11 (2015): 1548-55. doi:10.4088\/JCP.14m09267 (7) Unfer, Vittorio et al. \u201cEffects of Inositol(s) in Women with PCOS: A Systematic Review of Randomized Controlled Trials.\u201d International journal of endocrinology vol. 2016 (2016): 1849162. doi:10.1155\/2016\/1849162 (8) Papaleo, Enrico et al. \u201cMyo-inositol may improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial.\u201d Fertility and sterility vol. 91,5 (2009): 1750-4. doi:10.1016\/j.fertnstert.2008.01.088 (9) Raffone, Emanuela et al. \u201cInsulin sensitiser agents alone and in co-treatment with r-FSH for ovulation induction in PCOS women.\u201d Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology vol. 26,4 (2010): 275-80. doi:10.3109\/09513590903366996 (10) Minozzi, M et al. \u201cTreatment of hirsutism with myo-inositol: a prospective clinical study.\u201d Reproductive biomedicine online vol. 17,4 (2008): 579-82. doi:10.1016\/s1472-6483(10)60248-9 (11) Tahir, Faryal, and Zainab Majid. \u201cInositol Supplementation in the Prevention of Gestational Diabetes Mellitus.\u201d Cureus vol. 11,9 e5671. 16 Sep. 2019, doi:10.7759\/cureus.5671 (12) Giordano, Domenico et al. \u201cEffects of myo-inositol supplementation in postmenopausal women with metabolic syndrome: a perspective, randomized, placebo-controlled study.\u201d Menopause (New York, N.Y.) vol. 18,1 (2011): 102-4. doi:10.1097\/gme.0b013e3181e8e1b1 (13) Montanino Oliva, Mario et al. \u201cEffect of Myoinositol and Antioxidants on Sperm Quality in Men with Metabolic Syndrome.\u201d International journal of endocrinology vol. 2016 (2016): 1674950. doi:10.1155\/2016\/1674950 (14) Kontoangelos, Konstantinos et al. \u201cAdministration of inositol to a patient with bipolar disorder and psoriasis: a case report.\u201d Cases journal vol. 3 69. 23 Feb. 2010, doi:10.1186\/1757-1626-3-69 (15) Palatnik, A et al. \u201cDouble-blind, controlled, crossover trial of inositol versus fluvoxamine for the treatment of panic disorder.\u201d Journal of clinical psychopharmacology vol. 21,3 (2001): 335-9. doi:10.1097\/00004714-200106000-00014 (16) Brown, Laura D et al. \u201cInositol and mannose utilization rates in term and late-preterm infants exceed nutritional intakes.\u201d The Journal of nutrition vol. 139,9 (2009): 1648-52. doi:10.3945\/jn.109.109108<\/p>\n\n\n\n<\/details>\n\n<\/div>\n \n<\/div>\n","protected":false},"excerpt":{"rendered":"
Inozitolis galb\u016bt ir yra \u017einomas d\u0117l savo pagalbos PKS, bet tai toli gra\u017eu n\u0117ra vienintelis jo privalumas. Tai saldaus skonio milteliai, kuri\u0173 turb\u016bt galime rasti daugyb\u0117s moter\u0173 pirkini\u0173 krep\u0161eliuose, bet tai nerei\u0161kia, kad jie nepraverst\u0173 ir vyrams. Jei niekada anks\u010diau nevartojote inozitolio milteli\u0173, pasiruo\u0161kite nustebti! \u0160iame straipsnyje pasidalinsiu informacija apie inozitolio naud\u0105 sveikatai, vartojim\u0105 ir…<\/p>\n","protected":false},"author":2,"featured_media":129427,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"_kad_blocks_custom_css":"","_kad_blocks_head_custom_js":"","_kad_blocks_body_custom_js":"","_kad_blocks_footer_custom_js":"","_kad_post_transparent":"","_kad_post_title":"","_kad_post_layout":"","_kad_post_sidebar_id":"","_kad_post_content_style":"","_kad_post_vertical_padding":"","_kad_post_feature":"","_kad_post_feature_position":"","_kad_post_header":false,"_kad_post_footer":false,"_kad_post_classname":"","footnotes":""},"categories":[3015],"tags":[3025],"coauthors":[],"class_list":["post-236636","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-mityba","tag-chromositol-f"],"taxonomy_info":{"category":[{"value":3015,"label":"Mityba"}],"post_tag":[{"value":3025,"label":"Chromositol-F"}]},"featured_image_src_large":["https:\/\/eu.intelligentlabs.org\/wp-content\/uploads\/2020\/11\/inositol-powder-health-benefits-uses-and-dosage-01-1024x512.jpg",1024,512,true],"author_info":{"display_name":"David Pashley","author_link":"https:\/\/eu.intelligentlabs.org\/lt-lt\/author\/david\/"},"comment_info":0,"category_info":[{"term_id":3015,"name":"Mityba","slug":"mityba","term_group":0,"term_taxonomy_id":3015,"taxonomy":"category","description":"","parent":0,"count":45,"filter":"raw","cat_ID":3015,"category_count":45,"category_description":"","cat_name":"Mityba","category_nicename":"mityba","category_parent":0}],"tag_info":[{"term_id":3025,"name":"Chromositol-F","slug":"chromositol-f","term_group":0,"term_taxonomy_id":3025,"taxonomy":"post_tag","description":"","parent":0,"count":2,"filter":"raw"}],"wpml":{"language":"lt-lt","is_original":false,"original_post_id":131225,"translations":{"bg-bg":{"id":225768,"language":"bg-bg","is_original":false},"cs-cz":{"id":220761,"language":"cs-cz","is_original":false},"da-dk":{"id":222511,"language":"da-dk","is_original":false},"de-at":{"id":169512,"language":"de-at","is_original":false},"de-de":{"id":74881,"language":"de-de","is_original":false},"el-cy":{"id":229277,"language":"el-cy","is_original":false},"el-gr":{"id":228448,"language":"el-gr","is_original":false},"en-gb":{"id":131225,"language":"en-gb","is_original":true},"en-ie":{"id":165400,"language":"en-ie","is_original":false},"en-mt":{"id":165916,"language":"en-mt","is_original":false},"fi-fi":{"id":238663,"language":"fi-fi","is_original":false},"fr-fr":{"id":129426,"language":"fr-fr","is_original":false},"hu-hu":{"id":224903,"language":"hu-hu","is_original":false},"it-it":{"id":74758,"language":"it-it","is_original":false},"lt-lt":{"id":236636,"language":"lt-lt","is_original":false},"lv-lv":{"id":230618,"language":"lv-lv","is_original":false},"nl-be":{"id":217757,"language":"nl-be","is_original":false},"nl-nl":{"id":176786,"language":"nl-nl","is_original":false},"pl-pl":{"id":184112,"language":"pl-pl","is_original":false},"pt-pt":{"id":168840,"language":"pt-pt","is_original":false},"ro-ro":{"id":253672,"language":"ro-ro","is_original":false},"sk-sk":{"id":238829,"language":"sk-sk","is_original":false},"sl-si":{"id":239011,"language":"sl-si","is_original":false}}},"_links":{"self":[{"href":"https:\/\/eu.intelligentlabs.org\/lt-lt\/wp-json\/wp\/v2\/posts\/236636","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/eu.intelligentlabs.org\/lt-lt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/eu.intelligentlabs.org\/lt-lt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/eu.intelligentlabs.org\/lt-lt\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/eu.intelligentlabs.org\/lt-lt\/wp-json\/wp\/v2\/comments?post=236636"}],"version-history":[{"count":5,"href":"https:\/\/eu.intelligentlabs.org\/lt-lt\/wp-json\/wp\/v2\/posts\/236636\/revisions"}],"predecessor-version":[{"id":248357,"href":"https:\/\/eu.intelligentlabs.org\/lt-lt\/wp-json\/wp\/v2\/posts\/236636\/revisions\/248357"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/eu.intelligentlabs.org\/lt-lt\/wp-json\/wp\/v2\/media\/129427"}],"wp:attachment":[{"href":"https:\/\/eu.intelligentlabs.org\/lt-lt\/wp-json\/wp\/v2\/media?parent=236636"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/eu.intelligentlabs.org\/lt-lt\/wp-json\/wp\/v2\/categories?post=236636"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/eu.intelligentlabs.org\/lt-lt\/wp-json\/wp\/v2\/tags?post=236636"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/eu.intelligentlabs.org\/lt-lt\/wp-json\/wp\/v2\/coauthors?post=236636"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
![\"mio-inozitolis](\"https:\/\/eu.intelligentlabs.org\/lt-lt\/wp-content\/uploads\/sites\/44\/2021\/11\/image-1024x608.jpeg\")
<\/figure>\n<\/div>\n\n\n![\"Kod\u0117l](\"https:\/\/eu.intelligentlabs.org\/lt-lt\/wp-content\/uploads\/sites\/44\/2021\/11\/image-01-1024x538.jpeg\")
<\/figure>\n<\/div>\n\n\n![\"inozitolio](\"https:\/\/eu.intelligentlabs.org\/lt-lt\/wp-content\/uploads\/sites\/44\/2021\/11\/image-02-1024x530.jpeg\")
<\/figure>\n<\/div>\n\n\n![\"inozitolis](\"https:\/\/eu.intelligentlabs.org\/lt-lt\/wp-content\/uploads\/sites\/44\/2021\/11\/image-03-1024x516.jpeg\")
<\/figure>\n<\/div>\n\n\n![\"inozitolis](\"https:\/\/eu.intelligentlabs.org\/lt-lt\/wp-content\/uploads\/sites\/44\/2021\/11\/image-04-1024x618.jpeg\")
<\/figure>\n<\/div>\n\n\n![\"Inozitolis](\"https:\/\/eu.intelligentlabs.org\/lt-lt\/wp-content\/uploads\/sites\/44\/2021\/11\/image-05-1024x569.jpeg\")
<\/figure>\n<\/div>\n\n\n![\"inozitolio](\"https:\/\/eu.intelligentlabs.org\/lt-lt\/wp-content\/uploads\/sites\/44\/2021\/11\/image-06-1024x515.jpeg\")
<\/figure>\n<\/div>\n\n\n![\"inozitolis](\"https:\/\/eu.intelligentlabs.org\/lt-lt\/wp-content\/uploads\/sites\/44\/2021\/11\/image-08-1024x513.jpeg\")
<\/figure>\n<\/div>\n\n\n![\"inozitolio](\"https:\/\/eu.intelligentlabs.org\/lt-lt\/wp-content\/uploads\/sites\/44\/2021\/11\/image-09-1024x522.jpeg\")
<\/figure>\n<\/div>\n\n\n![\"mio-inozitolis](\"https:\/\/eu.intelligentlabs.org\/lt-lt\/wp-content\/uploads\/sites\/44\/2021\/11\/image-10-1024x521.jpeg\")
<\/figure>\n<\/div>\n\n\n![\"inozitolio](\"https:\/\/eu.intelligentlabs.org\/lt-lt\/wp-content\/uploads\/sites\/44\/2021\/11\/image-11-1024x518.jpeg\")
<\/figure>\n<\/div>\n\n\n![\"inozitolio](\"https:\/\/eu.intelligentlabs.org\/lt-lt\/wp-content\/uploads\/sites\/44\/2021\/11\/image-12-1024x520.jpeg\")
<\/figure>\n<\/div>\n\n\n